BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 11585736)

  • 1. Aspirin and the chemoprevention of cancers: A mathematical and evolutionary dynamics perspective.
    Komarova NL; Boland CR; Goel A; Wodarz D
    Wiley Interdiscip Rev Syst Biol Med; 2020 Sep; 12(5):e1487. PubMed ID: 32163237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: Functional redundancy between Apc and Apc2 regulates tissue homeostasis and prevents tumorigenesis in murine mammary epithelium.
    Daly CS; Shaw P; Ordonez LD; Williams GT; Quist J; Grigoriadis A; Van Es JH; Clevers H; Clarke AR; Reed KR
    Oncogene; 2024 Mar; 43(12):918. PubMed ID: 38263250
    [No Abstract]   [Full Text] [Related]  

  • 3. Nrf2 activation does not affect adenoma development in a mouse model of colorectal cancer.
    Knatko EV; Castro C; Higgins M; Zhang Y; Honda T; Henderson CJ; Wolf CR; Griffin JL; Dinkova-Kostova AT
    Commun Biol; 2021 Sep; 4(1):1081. PubMed ID: 34526660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
    Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
    mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin in the Prevention of Colorectal Neoplasia.
    Drew DA; Chan AT
    Annu Rev Med; 2021 Jan; 72():415-430. PubMed ID: 33035431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development.
    Davis JS; Kanikarla-Marie P; Gagea M; Yu PL; Fang D; Sebastian M; Yang P; Hawk E; Dashwood R; Lichtenberger LM; Menter D; Kopetz S
    BMC Cancer; 2020 Sep; 20(1):871. PubMed ID: 32912193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic low-dose aspirin treatment on tumor prevention in three mouse models of intestinal tumorigenesis.
    Rohwer N; Kühl AA; Ostermann AI; Hartung NM; Schebb NH; Zopf D; McDonald FM; Weylandt KH
    Cancer Med; 2020 Apr; 9(7):2535-2550. PubMed ID: 31994315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between NF-κB and Nucleoli in the Regulation of Cellular Homeostasis.
    Chen J; Stark LA
    Cells; 2018 Oct; 7(10):. PubMed ID: 30301139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin Prevention of Colorectal Cancer: Focus on NF-κB Signalling and the Nucleolus.
    Chen J; Stark LA
    Biomedicines; 2017 Jul; 5(3):. PubMed ID: 28718829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of hereditary colon cancers: time for new strategies.
    Ricciardiello L; Ahnen DJ; Lynch PM
    Nat Rev Gastroenterol Hepatol; 2016 Jun; 13(6):352-61. PubMed ID: 27095653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol and aspirin eliminate tetraploid cells for anticancer chemoprevention.
    Lissa D; Senovilla L; Rello-Varona S; Vitale I; Michaud M; Pietrocola F; Boilève A; Obrist F; Bordenave C; Garcia P; Michels J; Jemaà M; Kepp O; Castedo M; Kroemer G
    Proc Natl Acad Sci U S A; 2014 Feb; 111(8):3020-5. PubMed ID: 24516128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer and inflammation: an aspirin a day keeps the cancer at bay.
    Mione M; Zon LI
    Curr Biol; 2012 Jul; 22(13):R522-5. PubMed ID: 22789999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live imaging of tumor initiation in zebrafish larvae reveals a trophic role for leukocyte-derived PGE₂.
    Feng Y; Renshaw S; Martin P
    Curr Biol; 2012 Jul; 22(13):1253-9. PubMed ID: 22658594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin and low-dose nitric oxide-donating aspirin increase life span in a Lynch syndrome mouse model.
    McIlhatton MA; Tyler J; Kerepesi LA; Bocker-Edmonston T; Kucherlapati MH; Edelmann W; Kucherlapati R; Kopelovich L; Fishel R
    Cancer Prev Res (Phila); 2011 May; 4(5):684-93. PubMed ID: 21436383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the potential chemopreventive agent DMU-135 on adenoma development in the ApcMin+ mouse.
    Sale S; Tunstall RG; Ruparelia KC; Butler PC; Potter GA; Steward WP; Gescher AJ
    Invest New Drugs; 2006 Nov; 24(6):459-64. PubMed ID: 16505954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related difference in susceptibility of Apc(Min/+) mice towards the chemopreventive efficacy of dietary aspirin and curcumin.
    Perkins S; Clarke AR; Steward W; Gescher A
    Br J Cancer; 2003 May; 88(9):1480-3. PubMed ID: 12778080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system.
    Corpet DE; Pierre F
    Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):391-400. PubMed ID: 12750232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic utility of aspirin in the ApcMin/+ murine model of colon carcinogenesis.
    Reuter BK; Zhang XJ; Miller MJ
    BMC Cancer; 2002 Aug; 2():19. PubMed ID: 12171603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of intestinal and mammary neoplasia by lifetime administration of aspirin in Apc(Min/+) and Apc(Min/+), Msh2(-/-) mice.
    Sansom OJ; Stark LA; Dunlop MG; Clarke AR
    Cancer Res; 2001 Oct; 61(19):7060-4. PubMed ID: 11585736
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.